VFA
FOMX

Valeo Financial Advisors’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

Valeo Financial Advisors’s Portfolio FOMX Stock Details FOMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,500
Closed -$6K – 1705
2019
Q1 		$6K Buy
+1,500
New +$5.62K ﹤0.01% 1130

Other funds holding FOMX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Valeo Financial Advisors's FOMX Position: Q2 2019 in Review

Valeo Financial Advisors sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q2 2019, closing a stake of 1,500 shares — an estimated $6K sold.

Valeo Financial Advisors first reported a position in FOMX in Q1 2019 and held it in 1 quarter. The position peaked at $6K in Q1 2019. 58 funds tracked by Wall St. Rank hold FOMX as of Q2 2019.

  • Valeo Financial Advisors reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q2 2019 after selling out during the quarter.
  • Valeo Financial Advisors sold 1,500 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q2 2019, an estimated $6K.
  • Valeo Financial Advisors first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q1 2019 and held it in 1 quarter.
  • Valeo Financial Advisors's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $6K in Q1 2019.
  • 58 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q2 2019.

Based on Valeo Financial Advisors's 13F filing for Q2 2019, filed 10 Jul 2019.